ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2020 American Transplant Congress

    Public Education about Vascular Composite Allotransplantation and Donation: A Content Analysis of Social Media and Educational Documents

    S. Rasmussen1, M. Henderson1, N. Anderson2, J. Uriarte2, B. Doby1, C. Cooney1, D. Segev1, G. Brandacher1, E. Gordon2

    1Johns Hopkins, Baltimore, MD, 2Northwestern, Chicago, IL

    *Purpose: : Consistent and accurate public messaging is crucial in organ donation and transplantation, particularly in the emerging field of vascular composite allotransplantation (VCA). Currently,…
  • 2020 American Transplant Congress

    Pre-Transplant Pharmacogenetics Identifies CYP3A4 and CYP3A5 Heterogeneity among Caucasian Kidney Transplant Recipients

    N. Oliver1, L. Lindberg1, S. LeCorchick1, D. Morris1, S. Anand1, T. Srinivas2

    1Intermountain Medical Center, Murray, UT, 2University Hospitals Cleveland Medical Center, Cleveland, OH

    *Purpose: Tacrolimus has always been dosed based on therapeutic drug monitoring, however pharmacogenomics is becoming increasingly more utilized in the era of precision based medicine…
  • 2020 American Transplant Congress

    Vascularized Composite Allograft (VCA) Waiting List and Transplant Trends in the U.S

    J. Wainright1, C. Wholley2, W. Cherikh1, D. Klassen3

    1Research, UNOS, Richmond, VA, 2Policy and Community Relations, UNOS, Richmond, VA, 3Chief Medical Officer, UNOS, Richmond, VA

    *Purpose: Vascularized Composite Allograft (VCA) transplantation is a rapidly changing field. *Methods: Since the Organ Procurement and Transplantation Network (OPTN) implemented the VCA waiting list…
  • 2020 American Transplant Congress

    Informed Consent and Decision Making for Upper Extremity VCA

    B. Kuramitsu1, C. Berumen1, A. Ferzola2, H. Sung2, C. Kim3, D. Scarton3, T. McHugh3, A. Schultheis3, T. Riggleman3, J. Taylor3, M. Henderson2, G. Brandacher2, S. Tintle3, E. Gordon1

    1Northwestern U Feinberg Sch of Medicine, Chicago, IL, 2Johns Hopkins School of Medicine, Baltimore, MD, 3Walter Reed National Military Medical Center, Bethesda, MD

    *Purpose: The field of upper rxtremity (UE) Vascularized Composite Allotransplantation (VCA) continues to advance with more patients undergoing the informed consent process each year. However,…
  • 2020 American Transplant Congress

    Envarsus XR Use Can Benefit Serum Creatinine Levels in Vascularized Composite Allotransplantation Patients

    C. M. Cooney1, V. Javia1, J. Littleton1, D. S. Cooney1, R. J. Redett1, J. T. Shores1, D. C. Brennan2, G. Brandacher1

    1Plastic and Reconstructive Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, 2Surgery, Johns Hopkins University School of Medicine, Baltimore, MD

    *Purpose: Vascularized composite allotransplantation (VCA) is a life-enhancing (as opposed to life-saving) procedure. Therefore, minimizing adverse outcomes associated with chronic immunosuppression is vital to determining…
  • 2020 American Transplant Congress

    Pancreas Transplant in Patients Older Than 50: An Analysis of Outcomes and Immunosuppression

    I. Booth1, J. Casale1, S. Freedman1, B. Ravichandran1, J. Scalea2, A. Haririan2, B. Masters1

    1Pharmacy, University of Maryland Medical Center, Baltimore, MD, 2Medicine, University of Maryland Medical Center, Baltimore, MD

    *Purpose: Pancreas transplant (PT) is the ideal therapy for many patients with diabetes and kidney failure. There are limited published data addressing the impact of…
  • 2020 American Transplant Congress

    Utilization of High Terminal Creatinine Kidney Donors for Simultaneous Kidney and Pancreas Transplantation

    A. Montal, J. Torabi, N. Muhdi, J. Melvin, Y. Miura, M. Ajaimy, L. Lirano, Y. Azzi, C. Pynadath, E. Akalin, S. Greenstein, J. P. Rocca, J. A. Graham

    Montefiore Medical Center, Bronx, NY

    *Purpose: The use of kidneys with high terminal creatinine has been demonstrated in renal transplantation with excellent outcomes. Here we explore the use of high…
  • 2020 American Transplant Congress

    Single Center Experience with Allograft Pancreatectomy

    V. Gurram, A. Farney, J. Rogers, G. Orlando, C. Jay, R. Stratta, D. Harriman

    Abdominal Transplant Surgery, Wake Forest Baptist Health, Winston Salem, NC

    *Purpose: Limited data on indications for and outcomes following allograft pancreatectomy (AP) exist. The purpose of this study was to analyze our single center experience…
  • 2020 American Transplant Congress

    Induction of Delayed Immune Tolerance after Reconstructive Transplantation by Combining Donor Bone Marrow Transplantation and High-Dose Cyclophosphamide Treatment

    Y. Guo1, F. Messner1, B. Oh1, G. Furtmüller1, W. Lee1, D. Cooney1, L. Luznik2, G. Brandacher1

    1Plastic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, 2Hematology, Johns Hopkins University School of Medicine, Baltimore, MD

    *Purpose: Immunosuppression avoidance by induction of immune tolerance represents a primary goal in the field of transplantation. Yet, success of this concept relies on extensive…
  • 2020 American Transplant Congress

    Sodium Zirconium Cyclosilicate Use in Solid Organ Transplant Recipients and its Effect on Potassium and Immunosuppression

    R. Winstead, M. Demehin, I. Yakubu, C. Song, A. Brown, M. Levy, L. Kamal, G. Gupta

    VCU Health, Richmond, VA

    *Purpose: Transplant recipients often suffer from hyperkalemia which can limit pharmacotherapy. The cause of hyperkalemia is often multifactorial including kidney dysfunction, calcineurin inhibitor use, and…
  • « Previous Page
  • 1
  • …
  • 433
  • 434
  • 435
  • 436
  • 437
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences